Here's what we know about the new, experimental COVID antiviral pills — and when they might be available
Photo: Getty Images Vaccines against COVID-19 have been the key weapon for managing the coronavirus’ spread and fending off its most dangerous strains, but pills to treat the virus are on the horizon. So far, pharmaceutical giants Pfizer and Merck have developed experimental antiviral pills — called Paxlovid and molnupiravir, respectively — that have shown promising efficacy in clinical trials of adults with COVID-19.
The most significant difference between the COVID antiviral pills and the monoclonal antibody treatments for COVID that are already available is how much easier the pills would be to administer. Monoclonal antibody treatments are administered intravenously at a medical facility in a process which takes about an hour. The two oral medicine treatments are also expected to be less expensive than monoclonal antibody treatments.
It’s unclear if the Pfizer antiviral pill will also be considered at the panel, but the pharmaceutical company said it will submit its recent trial data in order to be considered for emergency authorization.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Covid-19: Booster jabs for over-40s and Northern Ireland considers Covid passportsFive things you need to know about the coronavirus pandemic this Monday evening.
Lire la suite »
CDC: Avoid Travel To These 3 New Destinations Due To Covid-19 RiskThe CDC has just moved Iceland, the Czech Republic, and Hungary up to Level 4, meaning that the Covid-19 risk is very high.
Lire la suite »
CDC: Avoid Travel To These 3 New Destinations Due To Covid-19 RiskThe CDC has just moved Iceland, the Czech Republic, and Hungary up to Level 4, meaning that the Covid-19 risk is very high.
Lire la suite »
Which states have opened COVID-19 vaccine boosters for all?A growing list of states are now moving ahead of federal authorization, recommending booster shots for all residents 18 years or older, six months after receiving their second COVID vaccine dose.
Lire la suite »
Sleep Disorders Could Raise the Risk of Severe COVID-19People with sleep disorders are no more likely than other adults to get infected with coronavirus and develop COVID-19. However, if infected, they are at a 31% higher risk of being hospitalized or dying from the illness, new research reveals:
Lire la suite »
NHL pauses Ottawa Senators' season due to Covid-19 outbreakThe NHL has halted the Ottawa Senators' season for at least a week because of a Covid-19 outbreak in the team
Lire la suite »